CapeStart TechBlog

That question led us to explore Orbital Brain, a conceptual architecture for applying LLMs to space mission operations.

The interesting part isn't autonomous spacecraft. It's using AI to help make sense of telemetry, connect signals across time, surface risks, and explain why a recommendation was made, while keeping humans responsible for every operational decision.

Sometimes the most valuable role for AI isn't taking action. It's helping people understand complex systems a little better.

Tables, symbols, layout, and source highlights all matter. That is why we moved our Summary-Level Extraction workflow from a LangChain + OCR-based setup to Anthropic’s native PDF understanding.

There's an important difference.

AI tools help complete individual tasks. AI agents can monitor, coordinate, integrate, and support entire workflows with context and autonomy.

For MedTech, that shift could change how intelligent systems operate, moving beyond automation toward workflow orchestration.

It's when a product stops being "something we built quickly" and becomes "something people depend on every day."

The code may not look very different.

The expectations do.

That's where the conversation shifts from shipping features to supporting growth, from intuition to ownership, from vibe coding to vibe engineering.

We unpacked what that transition looks like and why recognizing it early can save teams months of rework later.

Artificial Intelligence has enormous potential, but the reality is that many AI initiatives never make it beyond the pilot stage.

Interestingly, most failures aren't caused by the algorithms themselves. They're often the result of unclear goals, poor-quality data, unrealistic expectations, deployment challenges, or a lack of stakeholder adoption.

After analyzing real-world AI project failures, several common patterns emerged:

• A vague vision creates solutions without a clear business problem. • Data quality matters far more than data volume. • Complex models aren't always better than simpler, explainable alternatives. • Production deployment should be planned from the beginning, not treated as an afterthought. • AI systems require continuous monitoring and maintenance. • User trust and stakeholder buy-in are critical for long-term success.

The most successful AI projects combine strong technical execution with clear objectives, reliable data, operational readiness, and organizational alignment.

If you're planning an AI initiative or looking to improve an existing one, understanding these lessons can help you avoid costly mistakes and accelerate the path to real business value.

At first, everything feels simple.

One app. One environment. A few services. A few security rules.

Then suddenly, there are multiple teams, production workloads, staging environments, shared services, monitoring tools, firewalls, and routing rules everywhere.

That is where Hub-and-Spoke cloud architecture becomes useful.

The idea is simple:

A central hub manages shared services like security, connectivity, routing, monitoring, and governance.

The spokes handle individual applications, teams, or environments.

Instead of every workload managing everything separately, the architecture brings structure, control, and scalability into the cloud network.

It helps teams:

• reduce network complexity • centralize security • improve visibility • scale faster • manage cloud growth with less operational overhead

Sometimes, scaling well is not about adding more tools.

“AI will automate pharma workflows.”

Pharma teams: “Cool. Which workflow?”

AI: “…all of them?”

Meanwhile the actual workflow:

One system stores clinical data. Another stores safety reports. Regulatory documents live somewhere else. Market access teams use different evidence sources. Compliance wants audit trails. Legal wants human review. Everyone wants faster timelines.

And somehow all of this still runs on PDFs, spreadsheets, and approval chains.

That is why AI agents are becoming more interesting than basic copilots.

Not because they replace humans. Because they can coordinate workflows, connect systems, escalate edge cases, and keep traceability intact without turning operations into chaos.

That shift from “answer generation” to “workflow orchestration” might be where enterprise AI actually becomes useful.

AI hallucinations are weird because they don’t always look wrong.

Sometimes they look confident. Sometimes they sound polished. Sometimes they feel useful until someone checks the source.

That’s what makes them risky.

The real fix is not just “write better prompts.”

It’s better data. Better retrieval. Better review. Better monitoring.

Project management is changing.

Not in a “AI replaces managers” way, but in a quieter and more practical way.

The work is shifting from manual coordination to predictive orchestration. Instead of only tracking timelines, chasing updates, and reacting to risks, AI can help teams read delivery signals earlier, understand bottlenecks faster, and make project execution more visible.

Medical imaging AI is easy to imagine as a model looking at a scan.

But there is a quieter layer before that.

The scan has to be cleaned. The DICOM structure has to hold together. Metadata has to stay meaningful. Slices have to stay in the right order.

Small things, but not small consequences.

An Agent Factory connects multiple AI agents to handle complex workflows like pharmacovigilance, case triage, coding, signal detection, and compliance routing.

Each agent does a focused job. The orchestrator decides what happens next. Humans step in when judgment is needed.

That’s the real change:

From manual queues to parallel workflows. From isolated tools to coordinated decision systems. From AI outputs to audit-ready actions.

Most AI projects don’t fail because of the model. They fail because nothing works together.

A chatbot here. A copilot there. Everything looks fine until you connect it to real workflows like CRM, APIs, or internal tools. Then context breaks, outputs vary, and governance becomes a problem.

The shift is simple. Stop thinking about models. Start thinking about orchestration.

That’s when AI moves from experiments to something teams can actually use.

you don’t really notice a weak test automation setup at the start.

everything works. tests pass. coverage looks good.

and then a small UI change breaks 12 scripts.

you fix one → three more fail. you duplicate code just to “make it work.” suddenly, maintaining tests takes longer than writing them.

that’s usually not a tool issue. it’s a framework issue.

not because it tells you what was built, but because it shows how the work actually happened. the alignment, the iteration, the trust, the accountability.

NER found entities. LLMs understood context. RAG grounded outputs.

Now AI agents are starting to do the work.

Less about single answers. More about orchestrated, traceable workflows.

Generative AI changed how researchers interact with data. Scientists can summarize clinical studies, analyze research papers, and explore complex datasets in seconds.

But real pharmaceutical workflows are more complex than answering prompts. Drug discovery involves multiple steps such as analyzing evidence, validating safety data, coordinating experiments, and generating reports. Traditional GenAI tools can assist, but they cannot execute these workflows end to end.

This is where Agentic AI comes in.

Instead of isolated AI tools, organizations are exploring systems of specialized AI agents that can reason, act, and collaborate. One emerging concept is the Agent Factory, a platform designed to build, manage, and govern multiple AI agents working together across the drug discovery pipeline.

Rather than just generating insights, these agents can help plan tasks, retrieve data, validate results, and support decision making while keeping scientists in the loop.